Ignite Creation Date:
2025-12-24 @ 2:02 PM
Ignite Modification Date:
2025-12-27 @ 10:04 PM
Study NCT ID:
NCT05493995
Status:
COMPLETED
Last Update Posted:
2024-05-09
First Post:
2022-08-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer.
Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-21
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-01
Completion Date Type:
ACTUAL
First Submit Date:
2022-08-07
First Submit QC Date:
None
Study First Post Date:
2022-08-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-08
Last Update Post Date:
2024-05-09
Last Update Post Date Type:
ACTUAL